Regenerative medicines are headed for people with Parkinson’s disease or severe heart failure — but researchers are concerned about minimal clinical-trial data.

Human pluripotent stem-cells (HPSCs)—including human embryonic stem-cells and human induced pluripotent stem-cells—are reshaping the landscape of regenerative medicine.1,2 In Parkinson's disease, ...

In human cells, DNA carries chemical or "epigenetic" marks that decide how genes will be used in different tissues. Yet in a ...

Chinese scientists have achieved the world's first reversal of type-2 diabetes using stem-cell therapy. Here is what you need ...

Age-related memory decline and neurodegenerative diseases like Alzheimer's are often thought of as irreversible. But the brain is not static; neurons continually adjust the strength of their ...

A pioneering clinical trial is exploring whether lab-engineered stem cells can restore dopamine production in people with Parkinson’s disease.

Chinese researchers report the first reversal of type 2 diabetes using stem cell therapy, restoring natural insulin ...

Ordinary fat cells in obese animals can be induced to burn energy stores, generating substantial heat, according to a ...

The CL1 is the first commercial system from the same researchers who wowed the tech world in 2022 by teaching a cluster of ...

China has stunned the global medical community with a revolutionary cure for Type 2 diabetes, offering hope to millions ...